Apollo Hospitals Hyderabad gets JCI Accreditation
June 01, 2021
JCI accreditation involves methodical, rigorous process, including evaluation of performances in various areas
Apollo Hospitals, Hyderabad, has received the coveted Joint Commission International (JCI) Accreditation, for a record sixth time.
JCI is the internationally acknowledged gold standard for best clinical practices in quality and patient safety, which is renewed triennially. JCI Accreditation is the privilege of a select few reputed healthcare institutions, globally. The distinctive accreditation reiterates Apollo Hospitals’ commitment and constant endeavour to offer highest quality care and ensure utmost safety for patients.
“JCI accreditation is a testimony to Apollo’s dedication and commitment to deliver best possible care to patients. Apollo’s patient-centric approach and care on par with the best globally, enabled to conform with JCI’s strenuous parameters. Kudos to the team and the expert cl
Share this article
Share this article
PORTLAND, Ore., May 26, 2021 /PRNewswire/ Allied Market Research published a report, titled, Medical Device Security Market by Component (Solution and Service), Deployment Model (On-Premise and Cloud), Type (Endpoint Security, Network Security, Application Security, Cloud Security and Other), Device Type (Stationery Medical Devices, Internally Embedded Medical Devices and External Medical Devices & Consumer Wearables), and End User (Healthcare Institutions, Medical Device Manufacturers, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027. According to the report, the global medical device security industry generated $6.23 billion in 2019, and is estimated to garner $17.49 billion by 2027, portraying a CAGR of 13.8% from 2020 to 2027.
Centene Appoints Drew Asher as Chief Financial Officer
News provided by
Share this article
Share this article
ST. LOUIS, May 7, 2021 /PRNewswire/ Centene Corporation (NYSE: CNC) announced today that Drew Asher is appointed Executive Vice President and Chief Financial Officer, effective today. He will report to Michael Neidorff, Centene Chairman, President and CEO.
Mr. Asher is succeeding Jeffrey A. Schwaneke, who is rotating to the role of Executive Vice President of HealthCare Enterprises, in line with the company s rotation practice as part of our executive development. Mr. Schwaneke will report to Sarah London, President, Health Care Enterprises and Executive Vice President, Advanced Technology, HealthCare Enterprises. HealthCare Enterprises is a portfolio of high growth companies independent of Centene health plans, designing differentiated platform capabilities and delivering industry-leading products and services to third-party customers.
Explore Now
Mumbai: Shares of drug makers and healthcare companies were among the top performers on Wednesday boosted by the Reserve Bank of India’s move to provide an on-tap liquidity window of Rs 50,000 crore for the sector to fight Covid-19. Analysts said the announcement could push investors to raise their stakes in defensive sectors like pharma and technology as the second wave of the pandemic has reduced their appetite for cyclicals.
The Nifty Pharma index rallied 4 per cent on Wednesday as against the 1 per cent gains in the Nifty.
Sun Pharma, Lupin, Cadila Healthcare, Aurobindo and Torrent Pharma among others rallied more than 5 per cent.